| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.094 | 0.007 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.009 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |